7 found
Order:
Disambiguations
David J. Casarett [4]David Casarett [3]
  1.  16
    The Authority of the Clinical Ethicist.David J. Casarett, Frona Daskal & John Lantos - 1998 - Hastings Center Report 28 (6):6.
  2.  6
    A Taxonomy of Value in Clinical Research.David J. Casarett, Jason H. T. Karlawish & Jonathan D. Moreno - 2002 - IRB: Ethics & Human Research 24 (6):1.
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   4 citations  
  3.  6
    Open Label Extension Studies & the Ethical Design of Clinical Trials.David Casarett, Jason Karlawish, Pamela Sankar, Karen B. Hirschman & David A. Asch - 2001 - IRB: Ethics & Human Research 23 (4):1.
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  4.  51
    Innovation in Human Research Protection: The AbioCor Artificial Heart Trial.E. Haavi Morreim, George E. Webb, Harvey L. Gordon, Baruch Brody, David Casarett, Ken Rosenfeld, James Sabin, John D. Lantos, Barry Morenz, Robert Krouse & Stan Goodman - 2006 - American Journal of Bioethics 6 (5):W6-W16.
    Human clinical research has become a huge economic enterprise (Morin et al. 2002; Noah 2002). Because the human subject at the center can be so easily marginalized, many commentators recommend spec...
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  5. Index to Volume 20.Zlatko Anguelov, Piero Antuono, Jan Beyer, G. J. Boer, David J. Casarett, David Checkland, Jan De Lepeleire, Pieter F. De Vries Robbé, Arthur R. Derse & Edmund L. Erde - 1999 - Theoretical Medicine and Bioethics 20:599-603.
     
    Export citation  
     
    Bookmark  
  6.  75
    Moral perception and the pursuit of medical philosophy.David J. Casarett - 1999 - Theoretical Medicine and Bioethics 20 (2):125-139.
    This paper begins by examining the claim that the practice of medicine is essentially a moral endeavor. According to this view, all clinical practice has moral content, and each clinical situation has a moral dimension. I suggest that in order to recognize this moral dimension, clinicians must engage in an interpretive process, and that they must be able to interpret clinical data in ethical terms. However, clinicians often lack the ‘moral perception’ required to appreciate this moral dimension. I will argue (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  7.  17
    Why Insurance Companies Should Pay for Medical Cannabis.David Casarett & Donald I. Abrams - 2019 - American Journal of Bioethics 19 (4):8-10.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark